van der Weyden L, Papaspyropoulos A, Poulogiannis G, Rust A, Rashid M, Adams D, et al. Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res. 2012;72:3817-3827 pubmed publisher

Solomon D, Kim T, Diaz Martinez L, Fair J, Elkahloun A, Harris B, et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011;333:1039-43 pubmed publisher

Yee K, Grochola L, Hamilton G, Grawenda A, Bond E, Taubert H, et al. A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma. Cancer Res. 2012;72:2206-17 pubmed publisher